Innovating Works

DESTINA GENOMICA

Activa
ColoMARK: Identification and development of novel colorectal cancer biomarkers via state of the art liquid bio... DESTINA GENOMICA participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 The ColoMARK network integrates 17 teams with multidisciplinary expertise (omics, epidemiology, microbiome, circulating tumour DNA, bioinfor...
2022-07-06 - 2026-10-31 | Financiado
diaRNAgnosis: A novel platform for the direct profiling of circulating cell free ribonucleic acids in biofluids DESTINA GENOMICA tramitó un H2020: H2020-MSCA-RISE-2020 Circulating cell-free ribonucleic acids (ccfRNAs) represent an emerging and important class of molecules, able to provide significant clinic...
2020-10-02 - 2025-05-31 | Financiado
ARREST-TB: Accurate Rapid Robust and Economical diagnostic technoliogieS for Tuberculosis DESTINA GENOMICA participó en un H2020: H2020-SC1-BHC-2018-2020 This visionary project addresses the key needs of patients, clinicians and the World Health Organisations stated deliverables of affordable,...
2018-12-08 - 2021-06-30 | Financiado
Halo: Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets DESTINA GENOMICA participó en un H2020: H2020-MSCA-RISE-2016 The aim of this project is to expand upon a newly discovered platform reaction by developing new routes to Active Pharmaceutical Ingredients...
2016-12-14 - 2020-12-31 | Financiado
miRNA-DisEASY: microRNA biomarkers in an innovative biophotonic sensor kit for high specific diagnosis DESTINA GENOMICA participó en un H2020: H2020-MSCA-RISE-2015 Since 2001’s discovery of microRNAs (miRNAs) in humans, progress in genomics and transcriptomics has increased our comprehension of gene exp...
2015-11-20 - 2019-11-30 | Financiado
Liqbiopsens: Reliable Novel Liquid Biopsy technology for early detection of colorectal cancer DESTINA GENOMICA participó en un H2020: H2020-ICT-2015 The overall aim of LIQBIOPSENS project is the further development and validation in real settings of a novel diagnostic platform for the ear...
2015-10-30 - 2018-12-31 | Financiado
InnoBavaria_2: Enhancing the Innovation Management Capacity of SMEs in Bavaria DESTINA GENOMICA participó en un H2020: HORIZON-EIC-2021-InnovationProcurementAwardsPrize Overall objective of this proposed project is to contribute to smart growth in the European Union by increasing the efficiency and effective...
2015-08-17 - 2016-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.